About the Journal

European Journal of Medical Research and Clinical Trials is an international, peer-reviewed, open access journal dedicated to publishing high-quality research and scholarly contributions in the broad field of clinical medicine and healthcare. The journal provides a comprehensive platform for physicians, clinicians, medical researchers, healthcare professionals, and allied health experts to share innovative research findings, clinical advancements, evidence-based practices, and emerging developments that contribute to the improvement of healthcare and patient outcomes.

In an era of rapidly evolving medical technologies, diagnostic approaches, therapeutic interventions, and evidence-based healthcare practices, the dissemination of reliable and impactful clinical knowledge has become more important than ever. The European Journal of Medical Research and Clinical Trials is established with the vision of promoting excellence in medical research and facilitating the global exchange of scientific knowledge that bridges the gap between clinical research, medical innovation, and practical patient care.

The journal emphasizes the publication of original and significant contributions that advance the understanding of diseases and health conditions, improve diagnostic methodologies, evaluate therapeutic interventions, and promote effective approaches to disease prevention and patient management. By maintaining a strong commitment to scientific rigor and ethical publishing standards, the journal strives to ensure that all published content meets high standards of academic integrity, relevance, and quality.

As an international journal, European Journal of Medical Research and Clinical Trials welcomes submissions from researchers, clinicians, healthcare professionals, and academic institutions worldwide. The journal aims to encourage collaboration among experts from diverse medical specialties and disciplines, promoting the exchange of knowledge and ideas that can contribute to advancements in clinical research and healthcare delivery.

The journal provides equal opportunities for authors from around the world to disseminate their research, supporting inclusivity and diversity in scientific and medical communication. By encouraging global participation, the journal contributes to the advancement of clinical medicine and supports international efforts to improve disease prevention, diagnosis, treatment, and patient care.

Peer Review Excellence

The journal follows a rigorous double-blind peer review process, ensuring that both authors and reviewers remain anonymous throughout the evaluation process. This approach eliminates bias and guarantees a fair, objective, and transparent review of all submitted manuscripts.

Each submission undergoes a thorough assessment by qualified experts in the relevant field, who evaluate the manuscript based on originality, scientific validity, methodological soundness, and relevance to the journal’s focus. The editorial board carefully considers reviewers’ feedback before making final decisions regarding acceptance, revision, or rejection.

To meet the needs of researchers requiring timely publication, the journal also offers a fast-track review process, enabling rapid evaluation and publication of high-priority manuscripts without compromising the quality of peer review. This feature is particularly beneficial for time-sensitive research findings and emerging scientific developments.

Open Access Policy and Creative Commons Licensing

European Journal of Medical Research and Clinical Trials operates under a full open access publishing model, ensuring that all articles are freely accessible to readers worldwide without subscription barriers. This approach enhances the dissemination and impact of research, allowing knowledge to reach a broader audience including researchers, clinicians, policymakers, and the general public.

All published articles are distributed under Creative Commons licensing, which permits users to read, download, copy, distribute, and reproduce the content in any medium, provided that appropriate credit is given to the original authors. This policy supports the principles of transparency, accessibility, and knowledge sharing in scientific research.

Open access publishing not only increases the visibility of authors’ work but also contributes to higher citation rates and broader academic recognition.

Digital Identification and Indexing Support

To ensure the long-term accessibility and traceability of published research, the journal assigns a Digital Object Identifier (DOI) to each article through Crossref. This enables accurate citation, easy retrieval, and integration with global research databases.

In addition, all published articles are submitted for indexing in Google Scholar after publication, enhancing discoverability and ensuring that research is accessible to the global academic community. The journal continuously works toward inclusion in additional indexing and abstracting databases to further expand its reach and credibility

Language and Accessibility

The journal publishes all manuscripts in English, the universally accepted language of scientific communication. This ensures clarity, consistency, and accessibility for an international audience.

Authors are encouraged to present their research in a clear and concise manner, enabling readers from diverse academic and professional backgrounds to understand and apply the findings effectively. The journal also supports the use of standardized scientific terminology and formatting to maintain consistency across publications.

Ethical Standards and Integrity

The journal is committed to maintaining the highest standards of publication ethics and academic integrity. All submissions are expected to be original and free from plagiarism, data fabrication, or any form of unethical practice.

Authors are required to disclose any potential conflicts of interest and ensure that their research complies with ethical guidelines, particularly in studies involving human participants or animals. The journal follows internationally recognized ethical standards to safeguard the credibility and reliability of published research.

By enforcing strict ethical policies, the journal ensures trust among authors, reviewers, and readers.

Contribution to Scientific Advancement

The primary goal of the European Journal of Medical Research and Clinical Trials is to contribute meaningfully to the advancement of clinical medicine, medical research, and healthcare. By publishing high-quality research and encouraging interdisciplinary collaboration, the journal aims to support efforts to address complex health challenges and improve the quality of patient care.

The journal welcomes innovative and clinically relevant research that contributes to improved diagnostic approaches, effective therapeutic strategies, disease prevention, clinical decision-making, and patient management. It also encourages research that facilitates the translation of scientific discoveries into practical clinical applications that can benefit patients and healthcare systems.

Through its commitment to scientific excellence, accessibility, ethical integrity, and international collaboration, the journal aspires to serve as a valuable platform for the dissemination of contemporary medical and clinical knowledge.

widespread accessibility of scientific findings, the European Journal of Medical Research and Clinical Trials contributes to ongoing efforts to improve the understanding, diagnosis, prevention, and treatment of diseases while supporting better patient outcomes, advancing clinical practice, and promoting improved health and well-being worldwide.